Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InMode Ltd. (INMD : NSDQ)

• Company Description    InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel. Number of Employees: 362

• Price / Volume Information    Yesterday's Closing Price: $24.32 Daily Weekly Monthly 20 Day Moving Average: 2,934,701 shares Shares Outstanding: 83.24 (millions) Market Capitalization: $2,024.43 (millions) Beta: 2.12 52 Week High: $99.27 52 Week Low: $20.60 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.00% -12.67% 12 Week -41.51% -36.79% Year To Date -65.54% -59.19%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL TAVOR BUILDING SHAAR YOKNEAM POB 533 - YOKNEAM,L3 2069206 ISR ph: 972-4909-7470 fax: - ir@inmodemd.com http://www.inmodemd.com

• General Corporate Information    Officers Moshe Mizrahy - Chief Executive Officer and Chairman Shakil Lakhani - President Yair Malca - Chief Financial Officer Bruce Mann - Director Michael Anghel - Director Peer Information InMode Ltd. (BJCT) InMode Ltd. (CADMQ) InMode Ltd. (APNO) InMode Ltd. (UPDC) InMode Ltd. (IMTIQ) InMode Ltd. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: M5425M103 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 07/27/22 Share - Related Items Shares Outstanding: 83.24 Most Recent Split Date: 10.00 (2.00:1) Beta: 2.12 Market Capitalization: $2,024.43 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/27/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 12.44 PEG Ratio: - Price Ratios Price/Book: 5.02 Price/Cash Flow: 12.28 Price / Sales: 5.36 EPS Growth vs. Year Ago Period: 14.29% vs. Previous Quarter: -40.00% Sales Growth vs. Year Ago Period: 31.13% vs. Previous Quarter: -22.27% ROE 03/31/22 - 43.98 12/31/21 - 46.14 09/30/21 - 46.95 ROA 03/31/22 - 38.04 12/31/21 - 39.93 09/30/21 - 40.55 Current Ratio 03/31/22 - 9.13 12/31/21 - 9.07 09/30/21 - 8.17 Quick Ratio 03/31/22 - 8.63 12/31/21 - 8.66 09/30/21 - 7.81 Operating Margin 03/31/22 - 44.63 12/31/21 - 45.97 09/30/21 - 46.06 Net Margin 03/31/22 - 44.79 12/31/21 - 46.14 09/30/21 - 46.06 Pre-Tax Margin 03/31/22 - 46.72 12/31/21 - 46.99 09/30/21 - 46.68 Book Value 03/31/22 - 4.85 12/31/21 - 5.00 09/30/21 - 5.08 Inventory Turnover 03/31/22 - 2.82 12/31/21 - 2.92 09/30/21 - 2.81 Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©